MENU
MTVA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

MetaVia (MTVA) Ownership - Who owns MetaVia?

MetaVia Inc is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat cardiometabolic diseases... Show more

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
8.16M
P/E Ratio
N/A
Total Cash
13.73M
Projected Growth
N/A
Total Debt
194K
Revenue
N/A
Risk (Beta)
3.07
Dividend Yield
N/A
Total Cash/Share
2.66
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
MTVA
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Details